HSA — authorised 22 June 1982
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: likely_approved
🇸🇬 Renacidin in Singapore
HSA authorised Renacidin on 22 June 1982
Marketing authorisation
Renacidin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in Singapore
Frequently asked questions
Is Renacidin approved in Singapore?
Yes. HSA authorised it on 22 June 1982.
Who is the marketing authorisation holder for Renacidin in Singapore?
BAXTER HLTHCARE holds the Singaporean marketing authorisation.